European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading

European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,

MT NewswiresApr 25 23:06

Abstract for Longer-term Follow-up and Additional Data Analysis of Pivotal Phase 2 FELIX Study of Obe-cel for Adult R/r B-ALL Selected for an Oral Presentation at ASCO

LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the abstract

GlobeNewswireApr 24 22:00

Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced

GlobeNewswireApr 23 19:00

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down

European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains

MT NewswiresApr 19 23:10

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading

European equities traded in the US as American depositary receipts were treading water in Thursday morning session, nudging 0.006% higher to 1,330.06 on the S&P Europe Select ADR Index. From continent

MT NewswiresApr 18 23:08

Needham: Reiterated the Autolus Therapeutics (AUTL.US) rating, adjusted from buy to buy rating, target price of $9.00.

Needham: Reiterated the Autolus Therapeutics (AUTL.US) rating, adjusted from buy to buy rating, target price of $9.00.

Zhitong FinanceApr 12 18:10